http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2014127326-A

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y207-02007
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y103-99002
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y402-01017
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y602-01002
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-93
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P7-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-001
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-1217
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-0004
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P7-42
filingDate 2012-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2016-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2014127326-A
titleOfInvention Biotechnological production of 3-hydroxyisobutyric acid
abstract 1. A method comprising the following steps: a) providing isobutyric acid, b) contacting isobutyric acid with a combination of isobutyrate kinase and phosphotransisobutyrylase and / or isobutyryl-Coenzyme A synthase / ligase and / or isobutyrate-Coenzyme A transferase, c) administration the product from step b) into contact with isobutyryl-Coenzyme A-dehydrogenase, d) introducing the product from step c) into contact with methacryl-Coenzyme A-hydrate, e) hydrolysis of the product from step d) to form 3-hydroxyisobutyric acid, where at least one of the enzymes used in stages b), c) and d) from the group of isobutyrate kinase, phosphotransisobutyrylase, isobutyryl-coenzyme A synthase / ligase and isobutyrate-coenzyme A-transferase, preferably all, are provided in the form of a cell which, compared to its wild type, has a reduced activity of 3-hydroxyisobutyric acid dehydrogenase or a variant thereof. 2. A method according to claim 1, wherein isobutyric acid is formed by contacting isobutane with a monooxygenase, preferably an alkane hydroxylase, more preferably an AlkBGT type or a variant thereof. The method of claim 1, wherein the hydrolysis in step d) is achieved by contacting the product from step d) with 3-hydroxyisobutyryl-Coenzyme A-hydrolase. The method of claim 1, wherein the cell contains both isobutyryl-coenzyme A dehydrogenase from step c) and methacrylyl-coenzyme A hydratase from step d), as well as a combination of isobutyrate kinase and phosphotransisobutyrylase and / or isobutyryl-coenzyme A synth ligase and / or isobutyrate-coenzyme A transferase. 5. The method of claim 1, wherein the cell further comprises an alkane hydroxylase, preferably an AlkBGT-type or variant thereof. The method of claim 1, wherein 3-hydroxyisobutyric acid dehydrogenase is
priorityDate 2011-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID165390
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID515340
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID28
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID4952
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID563897
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6590
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID80908
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID44793
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID301384
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419590168
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410627549
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID4952
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419531089
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100301568
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID227095
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100037216
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408184744
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID65270
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID113266557
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID8615912
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID41869
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID4932
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527425
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3036931
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID4932
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6360
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID26275
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID548942
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID103679933
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID798364

Total number of triples: 51.